Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glycation and Serum Albumin Infiltration Contribute to the Structural Degeneration of Bioprosthetic Heart Valves.
Frasca A, Xue Y, Kossar AP, Keeney S, Rock C, Zakharchenko A, Streeter M, Gorman RC, Grau JB, George I, Bavaria JE, Krieger A, Spiegel DA, Levy RJ, Ferrari G. Frasca A, et al. Among authors: krieger a. JACC Basic Transl Sci. 2020 Aug 5;5(8):755-766. doi: 10.1016/j.jacbts.2020.06.008. eCollection 2020 Aug. JACC Basic Transl Sci. 2020. PMID: 32875167 Free PMC article.
Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen structure and mechanical properties.
Rock CA, Keeney S, Zakharchenko A, Takano H, Spiegel DA, Krieger AM, Ferrari G, Levy RJ. Rock CA, et al. Among authors: krieger am. Acta Biomater. 2021 Mar 15;123:275-285. doi: 10.1016/j.actbio.2020.12.053. Epub 2021 Jan 11. Acta Biomater. 2021. PMID: 33444798 Free PMC article.
Inhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents and anticalcification interactions with ethanol pretreatment.
Zakharchenko A, Rock CA, Thomas TE, Keeney S, Hall EJ, Takano H, Krieger AM, Ferrari G, Levy RJ. Zakharchenko A, et al. Among authors: krieger am. Biomaterials. 2022 Oct;289:121782. doi: 10.1016/j.biomaterials.2022.121782. Epub 2022 Sep 6. Biomaterials. 2022. PMID: 36099713 Free PMC article.
Poly-2-methyl-2-oxazoline-modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration.
Zakharchenko A, Xue Y, Keeney S, Rock CA, Alferiev IS, Stachelek SJ, Takano H, Thomas T, Nagaswami C, Krieger AM, Chorny M, Ferrari G, Levy RJ. Zakharchenko A, et al. Among authors: krieger am. Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):e2120694119. doi: 10.1073/pnas.2120694119. Proc Natl Acad Sci U S A. 2022. PMID: 35131859 Free PMC article.
Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism.
Horev G, Ellegood J, Lerch JP, Son YE, Muthuswamy L, Vogel H, Krieger AM, Buja A, Henkelman RM, Wigler M, Mills AA. Horev G, et al. Among authors: krieger am. Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17076-81. doi: 10.1073/pnas.1114042108. Epub 2011 Oct 3. Proc Natl Acad Sci U S A. 2011. PMID: 21969575 Free PMC article.
Rates of contributory de novo mutation in high and low-risk autism families.
Yoon S, Munoz A, Yamrom B, Lee YH, Andrews P, Marks S, Wang Z, Reeves C, Winterkorn L, Krieger AM, Buja A, Pradhan K, Ronemus M, Baldwin KK, Levy D, Wigler M, Iossifov I. Yoon S, et al. Among authors: krieger am. Commun Biol. 2021 Sep 1;4(1):1026. doi: 10.1038/s42003-021-02533-z. Commun Biol. 2021. PMID: 34471188 Free PMC article.
Rare de novo and transmitted copy-number variation in autistic spectrum disorders.
Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, Marks S, Lakshmi B, Pai D, Ye K, Buja A, Krieger A, Yoon S, Troge J, Rodgers L, Iossifov I, Wigler M. Levy D, et al. Among authors: krieger a. Neuron. 2011 Jun 9;70(5):886-97. doi: 10.1016/j.neuron.2011.05.015. Neuron. 2011. PMID: 21658582 Free article.
440 results